Stay updated on Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Additions clarify that publications are provided voluntarily by the enterer and are auto-filled from PubMed, with the Revision: v3.3.2 noted. Deletions remove older phrasings about the source and scope of PubMed listings (and the older Revision: v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-24T17:48:01.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed a site-wide notice about government funding and NIH operating status. This change does not affect the study information or how users interact with the study record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T17:16:47.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The changes appear limited to page formatting and minor text updates. There is no modification to core study details, eligibility criteria, endpoints, or listed locations.
    Difference
    0.2%
    Check dated 2025-11-03T09:53:02.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Update to references and versioning: add new 2025 publications and DOIs, replace prior ahead-of-print items with current ones, and increment revision to v3.2.0 while removing earlier cited items (v3.1.0). Also add a government status notice.
    Difference
    3%
    Check dated 2025-10-05T14:35:22.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page has updated its version to v3.1.0 and removed several pharmaceutical topics (Drug Safety, Counterfeit Drugs, Placebos, Substandard Drugs, Therapeutics, Pharmaceutical Preparations) and the older revision tag v3.0.2, indicating a scope reduction and a new versioning label.
    Difference
    0.3%
    Check dated 2025-09-28T09:57:31.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page version was updated from v3.0.1 to v3.0.2. The 'Back to Top' navigation element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:13:36.000Z thumbnail image

Stay in the know with updates to Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page.